Rx · PZN 01126387

LEVODOPA Benserazid-CT 50 mg/12,5 mg tablets

German trade nameLEVODOPA Benserazid-CT 50 mg-12,5 mg Tabletten

Active ingredientLevodopa and decarboxylase inhibitorSubstance (DE)Levodopa und Decarboxylasehemmer*Pharmaceutical formTablets

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Storage temperature and transport temperature

Ambient max. 25 °C

Highest known
purchase price (B2B)

~ €6

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for LEVODOPA Benserazid-CT 50 mg/12,5 mg tablets.

Review purchasing terms

LEVODOPA Benserazid-CT 50 mg/12,5 mg tablets contains the active ingredient Levodopa and decarboxylase inhibitor (German Levodopa und Decarboxylasehemmer*) and comes as Tablets. One pack size is recorded (PZN 01126387). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.

LEVODOPA Benserazid-CT 50 mg/12,5 mg tablets was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.